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Urologist led one-stop testicular clinic: 
the UK ’gold standard’
David Muthuveloe1*, Nkwam Nkwam2, Paul Hutton3, D. M. A. Wallace3, Richard Viney3 and Prashant Patel1
Abstract 
Prompt diagnosis and early treatment for testicular cancer is vital. To help with this a one-stop, urologist run, testicular 
clinic with testicular ultrasound scanning as an integral part of the clinic format was introduced to investigate patients 
in an efficient and timely manner. The aim of this study was to assess the feasibility and efficiency of running a one-
stop testicular clinic. A prospectively collected electronic database of all patients attending a one-stop testicular clinic 
at a busy university hospital was interrogated over a 6-year period. Only new referral males, above the age of 15 years 
old were included. Case notes were reviewed retrospectively. A total of 1757 patients were found with a median 
age of 36. 6.3 % had a suspicious ultrasound scan and overall 5.6 % were found to have malignancy histologically. In 
addition a significant proportion of men with a history of testicular maldescent went on to develop testicular cancer 
(p < 0.01). Median time from referral to clinic and clinic to orchidectomy for suspected testicular cancers was 9 and 
5 days respectively (95 % CI). Some of the benefits of a urologist run one-stop testicular clinic include: timely diagnosis 
and treatment, early reassurance with normal investigations, the discovery of clinically unsuspecting malignancy and 
the increase in teaching opportunities. These collective benefits must improve patient experience and benefit the 
department as a whole. A urologist led one-stop testicular clinic should be regarded as the gold standard.
Keywords: Testicular cancer, Rapid access testicular clinic, One-stop testicular clinic
© 2016 Muthuveloe et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made.
Background
Testicular cancer accounts for approximately 1  % of all 
the malignancies found in the general male population 
(La Vecchia et al. 2010). In 2011 it was rated 16th most 
common male cancer in the UK (Office for National sta-
tistics 2013), however it is the most frequent cancer iden-
tified in men between the ages of 15–35. Over the last 
three to four decades the incidence of testicular cancer 
world wide has increased and in the UK the incidence has 
doubled (Huyghe et al. 2003; Albers et al. 2005). Reassur-
ingly with effective treatment, testicular cancer is highly 
curable (Viatori 2012). Early diagnosis and treatment 
is a high priority in these cases and healthcare workers 
must be aware of the importance in education for the 
young male population. A one-stop testicular clinic was 
introduced to facilitate the investigation and treatment of 
patients in an efficient, timely and effective manner.
The aim of this investigation was to assess the feasibil-
ity and efficiency of running a one-stop testicular clinic.
Urologist led one‑stop testicular clinic
To help with rapid investigation and diagnosis, a urolo-
gist led one-stop testicular clinic with testicular ultra-
sound scanning was created. According to the United 
Kingdom national guidelines patients who are referred 
to a urologist with a possible malignant testicular mass 
must be seen within 2 weeks, however this does not nec-
essarily mean that a diagnosis or treatment plan has been 
implemented. Often the first clinic appointment ena-
bles history and examination by a urologist but further 
investigations are often required. Blood tests and ultra-
sound scans are invariably needed to make a final diag-
nosis and treatment plan, which all require further clinic 
appointments.
The rationale of a urologist led one-stop testicular 
clinic was to expedite the patient’s journey through from 
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referral to diagnosis and then to treatment (Kendall et al. 
1996). Testicular ultrasound scanning forms an integral 
part of the clinic format. The key personnel required to 
run these clinics are a urologist who takes a detailed his-
tory and examination, and a testicular cancer specialist 
nurse. Facilities for phlebotomy and for testicular ultra-
sound scanning (to be done ideally by the urologist) have 
to be available and the appropriate patient literature on 
all testicular pathology needs to be present. This type of 
clinic format would result in a prompt patient journey 
from referral to diagnosis.
Methods
A prospectively collected electronic database of all 
patients attending a one-stop testicular clinic at a busy 
university hospital was interrogated over a 6-year period. 
Only new referral males, above the age of 15  year old 
were included. Case notes were reviewed retrospectively. 
Patient risk factors, referral details and clinic letters were 
examined. Ultrasound results were compared to final 
histology results for concurrence. The testicular tumor 
markers alpha feto-protein (αFP), beta human chorionic 
gonadotropin (βhcg) and lactate dehydrogenase (LDH) 
were also analyzed.
Results
A total of 1757 patients were seen over a period of 
67  months. The overall detection rate for malignancy 
was 5.6  % (98 cases). The overall median age was 36 
(15–92). In those with histologically proven malignancy 
the median age was 31 (17–82), which was significantly 
lower than those without malignancy (p  <  0.05). 6  % of 
cases between the ages of 15 and 34 were found to have 
a malignancy compared to 3 % of cases that had a malig-
nancy above the age of 34. Therefore there was almost 
twice the likelihood of being diagnosed with malignancy 
in the younger age group (RR 1.9). The median duration 
of symptoms was 8 weeks. There was almost equal split 
in laterality with 47 % of cases on the left, 45 % of cases 
on the right and 8 % of cases were bilateral.
Median waiting time to be seen for all patients was 
13  days (95  % CI). For those with testicular cancer the 
median waiting time to be seen was 9 days (95 % CI). The 
median waiting time from clinic to orchidectomy was 
5 days (95 % CI).
1740 (99 %) had testicular ultrasound scans. 109 cases 
(6.3 %) had an ultrasound scan that appeared suspicious 
of testicular cancer. 17.9 % had no abnormalities on ultra-
sound scan and the rest had benign lesions. The major-
ity of these benign lesions were epididymal cysts (31.6 %), 
epididymo-orchitis (20.8  %) and hydroceles (10.7  %) 
(Fig. 1).
98 out of the 109 cases with abnormal ultrasound scans 
were subsequently found to have malignancy on histolog-
ical examination. Therefore when compared to the ultra-
sound findings there were 11 false positives (Table 1).
The most common histology result for those with 
malignancy was seminomatous germ cell tumor (51 %) as 
shown in Fig. 2.
5.7  % of the men with testicular cancer had a history 
of maldescended testes in the past. This compares with 
1.4  % who did not have cancer who had a history of 
maldescended testes. As a result a significant proportion 
of men with a history of maldescended testicles went on 
to develop testicle cancer (p < 0.01) giving a relative risk 
of 4.1.
Overall 51.5 % of those with testicular germ cell tumors 
(GCT) were found to have a raised serum testicular 
tumor marker (αFP, βhcg or LDH). 47 % of seminomas, 
54 % of NSGCT and 60 % of mixed GCT had at least one 
or more raised serum testicular tumor marker (Fig. 3).
Discussion
Following the release by the UK National Health Ser-
vice (NHS) Modernization Agency in 2004 (NHS Mod-
ernisation Agency 2004) of advice relating to service 
improvement, three of the ten high impact changes were 
particularly pertinent to these clinics. They included 
the help to improve access to key diagnostic tests, avoid 
unnecessary follow-ups and improve patient access by 
reducing the number of queues. Subsequently the rule 
that those with suspected cancer should be seen within 
2 weeks became well established (Kendall et al. 1996). In 
urology the one-stop clinics was a natural follow-on and 
this has been established in those patients with suspected 
prostate cancer and those with hematuria. However the 
appetite for a one-stop testicular clinic has been lacking 
and has not been widely accepted.
There are many apparent benefits from having a rapid 
access one-stop testicular cancer clinic. Primarily it 
reduces the multiple attendances that a patient has to go 
through to get a diagnosis. This helps with faster diagno-
sis and treatment. In our group we found a median wait-
ing time of those with testicular malignancy of 9  days 
and a median waiting time from clinic to orchidectomy 
of 5 days. Prompt diagnosis and scheduling for treatment 
must also help reduce the risk of complications and must 
benefit the department as a whole. In addition it helps 
alleviate patient anxiety in those with normal examina-
tions and normal investigations.
The ease of access for general practitioners (GPs) to 
this service is useful and should be regarded as benefi-
cial. However it could be argued that the improved ser-
vice could increase referral rates, as some GPs may not 
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be confident to reassure patients based on examination 
alone. This lack of confidence is not an unreasonable 
concern as approximately 2200 new cases of testicular 
malignancy are diagnosed each year in the UK (Cancer 
Research UK 2012), GPs may only see one or two cases 
of testicular malignancy in their lifetime. This is sup-
ported by a study from Gloucester that showed that up 
to 81 % of 2 week wait referrals to testicular clinic when 
subsequently examined by a specialist were thought 
to be inappropriate (Foster et  al. 2006). As a result the 
improved service may stimulate demand. However our 
results show that the referral rates did not increase year 
on year but in fact remained stable. This is thought to be 
due to the reduction of clinic re-attenders caused by the 
prompt reassurance of a normal examination and ultra-
sound scans.
Routine testicular ultrasound is an integral part of the 
one-stop testicular clinic. A urologist who is trained in 
scrotal ultrasound scanning is needed for this service. 
This can be a controversial issue as not only is it tak-
ing work and possibly funding away from the radiol-
ogy department; the radiology department may become 
deskilled in this area. This problem can be addressed 
by having an instant access ultrasonographer available 
alongside the clinic to do the scan; however in the clinic 
analyzed, an appropriately trained urologist performed 
the ultrasound scan.
Another controversial issue is the reliability of an 
ultrasound scan performed by a urologist. Ultrasound 
scrotum like any other ultrasound procedure is opera-
tor dependent and there may be some concern as to the 
accuracy of the result. However in this study we have 
Fig. 1 A chart describing all testicular ultrasound scans results
Table 1 The histology results for those cases with a suspi‑
cious testicular ultrasound scan but no malignancy on his‑
tology
Frequency
Epidermoid cyst 3
Tuberculous orchitis 2
Chronic active epididymoorchitis 2
Testicular microlithiasis 2
Not malignant 2
Total 11
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shown that in the hands of an urologist trained in scro-
tal ultrasound there is excellent accuracy in diagnosing 
malignancy with a 90 % specificity rate. This is compara-
ble to previously published literature (Polák and Hornák 
1990; Guthrie and Fowler 1992). This means that with an 
appropriately trained urologist there is good evidence 
that the ultrasound results are robust and should be 
reliable.
The liberality of ultrasonography in these cases could 
be of some debate. In a one-stop clinic almost every 
patient had a testicular ultrasound scan (99 %) regardless 
of the examination findings. It could be argued that there 
Fig. 2 A pie chart showing all the types of malignancy found following orchidectomy
Fig. 3 Proportion of germ cell tumor cases with positive testicular tumor markers (αFP, βhcg, LDH)
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was over-investigation in some cases especially if the clin-
ical examination was normal or showed benign disease. 
In the normal situation if a urologist felt that the exami-
nation was normal or the patient had benign disease then 
a formal ultrasound scan may not necessarily have been 
requested. However we the authors disagree with this 
assumption. This is due to the fact that the examination 
findings are not always reliable and may miss small clini-
cally unsuspecting disease. In addition there may be dual 
pathology. One study found that 1.3  % of patients with 
a clinical diagnosis of epididymal cyst (mainly by urolo-
gists) were found to have a malignancy on subsequent 
ultrasound scan (Guthrie and Fowler 1992). This shows 
that examination, although useful shouldn’t necessarily 
be relied upon completely and that as ultrasound scan-
ning is quick, relatively cost effective and non-invasive it 
should be used.
A further advantage of this clinic set up is the excellent 
environment for urological trainees to gain concentrated 
experience in testicular ultrasound and for medical stu-
dents to gain experience in male genital examination. 
Learning opportunities around these areas can be dif-
ficult to come across during training however this clinic 
would provide the ideal occasion to teach these key skills.
It is well established that cryptorchidism is a risk fac-
tor for testicular cancer (Kundra 2004). We found that a 
significant number of those with testicular cancer had a 
history of testicular maldescent (p  <  0.01). A history of 
testicular maldescent was found to be a significant inde-
pendent predictive marker of being diagnosed with tes-
ticular cancer with 4 out of the 22 (18 %) being diagnosed 
with testicular cancer when referred to testicular clinic. 
Several studies have shown the relative risk of testicular 
cancer in those with testicular maldescent ranges from 
2.1 to 17.6 (Herrinton 2003) and our study supports this 
with a relative risk of 4.5 in those who were referred to 
testicular clinic.
Conclusion
With a urologist led one-stop testicular clinic we have 
shown not only convenience for patients and referring 
doctors, but also a fast referral to clinic time and a fast 
referral to treatment time in those with suspected tes-
ticular cancer. This benefits patients and leads to less 
anxiety as diagnoses are made rapidly. In addition the 
reassurance of a normal or benign ultrasound scan would 
reduce the number of re-attenders. We have also shown 
that an appropriately trained urologist can perform tes-
ticular ultrasound scans with high accuracy and specific-
ity comparable to previously published data. This saves 
time and also departmental funds. We believe that these 
collective enhancements are positive and benefit patients 
and the department as a whole. A urologist led one-stop 
testicular clinic should be regarded as the gold standard.
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